Lenalid 5mg Capsule

Lenalid 5mg Capsule is a prescription-based anticancer drug that should be administered orally. It is advised to take this capsule after consulting your healthcare expert. This capsule should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.

Lenalid 5mg Capsule comes under the category of medicines termed as Immunomodulatory agents. The active ingredient of this anticancer drug is Lenalidomide. This Capsule strengthens the immune system to attack cancer cells. This medicine stops the formation of new blood vessels from growing in cancer cells. It also reduces the production of chemical messengers that help cancer cells multiply uncontrollably and kill the abnormal cancer cells in the bone marrow. Also it helps in the production of normal blood cells.

It is advised not to miss any scheduled dosage of Lenalid 5mg Capsule. In case you miss a dose, consult your doctor immediately.

Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.

It is advised to go for regular blood tests before and during the treatment as Lenalid 5mg Capsule may lead to a reduction in WBC (white blood cells) and platelets. These components are required to fight infections in the body.

Avoid physical work that may result in bruising or injury. Stay away from people having colds or infections.

Lenalid 5mg Capsule makes your skin sensitive to sunlight as one of the side effects. Always apply sunscreen when going out.

Dehydration is a symptom observed after taking Lenalid 5mg Capsule. Drink enough water to maintain the hydration level while taking medication.

Inform your dentist before receiving any dental care that you're undergoing treatment with Lenalid 5mg Capsule.

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1. Fink, E. C., & Ebert, B. L. (2015). The novel mechanism of lenalidomide activity. Blood, The Journal of the American Society of Hematology, 126(21), 2366-2369.
2. Lee, S., Hwang, J. G., Park, S. Y., Lim, H. J., Lee, S. W., Seo, M. H., ... & Hong, J. H. (2018). Single-dose comparative pharmacokinetics of two formulations of lenalidomide 25 mg in healthy subjects: a randomized crossover study. Advances in Therapy, 35(2), 210-217.
3. Lindfelt, T., & Ignoffo, R. (2012). Oral Chemotherapy (Part II): What Every Pharmacist Should Know. California Journal of Health-System Pharmacy, 24(5).
4. Rao, K. V. (2007). Lenalidomide in the treatment of multiple myeloma. American Journal of Health-System Pharmacy, 64(17), 1799-1807.
5. Kotla, V., Goel, S., Nischal, S., Heuck, C., Vivek, K., Das, B., & Verma, A. (2009). Mechanism of action of lenalidomide in hematological malignancies. Journal of hematology & oncology, 2(1), 36.
6. Armoiry, X., Aulagner, G., & Facon, T. (2008). Lenalidomide in the treatment of multiple myeloma: a review. Journal of clinical pharmacy and therapeutics, 33(3), 219-226.